داروسازی تهران شیمی
شتهران | Stocks - Iran Fara Bourse (IFB)
داروهای شیمیایی و گیاهی
Sector:
داروهای شیمیایی و گیاهی
Market Type:
Stocks
Status:
Closed
Last Price: 1,000 0.00
Close Price: 6,830
Income Statement
AGM
Interim
2026/05/02 Fiscal Year 2025/12/2112 Month | 2025/10/04 Fiscal Year 2024/12/2012 Month | 2024/10/02 Fiscal Year 2023/12/2112 Month | ||
|---|---|---|---|---|
Revenue from Services & Sales | 40.892 Trillion | 28.298 Trillion | 29.223 Trillion | |
Total Revenues | 40.892 Trillion | 28.298 Trillion | 29.223 Trillion | |
Cost of Goods Sold | 26.913 Trillion | 21.252 Trillion | 18.63 Trillion | |
Gross Profit | 13.979 Trillion | 7.046 Trillion | 10.593 Trillion | |
General & Administrative Expenses | 1.976 Trillion | 1.672 Trillion | 939.743 Billion | |
Operating Profit (Loss) | 12.004 Trillion | 5.374 Trillion | 9.653 Trillion | |
Profit Before Tax | 9.763 Trillion | 2.075 Trillion | 9.705 Trillion | |
Tax | 1.298 Trillion | 147.075 Billion | 209.558 Billion | |
Net Profit (Loss) After Tax | 8.464 Trillion | 1.928 Trillion | 9.496 Trillion | |
Retained Earnings at Beginning of Period | 9.121 Trillion | 14.453 Trillion | 6.494 Trillion | |
Approved Dividends — Prior Year AGM | -1.006 Trillion | -2.011 Trillion | -311.85 Billion | |
Capital Decrease (Increase) from Accumulated Losses (Retained Earnings) | - | -5.146 Trillion | -1.114 Trillion | |
Allocable Profit | 16.579 Trillion | 9.224 Trillion | 14.564 Trillion | |
Legal Reserve | 410.78 Billion | 103.773 Billion | 111.375 Billion | |
Approved Dividends — Current Year | 1.341 Trillion | 1.006 Trillion | 2.011 Trillion | |
Retained Earnings at End of Period | 14.828 Trillion | 8.115 Trillion | 12.442 Trillion |